Association Between Pre-Kidney Transplantation Elevated Parathyroid Hormone and Posttransplantation Graft Loss.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 38895942.
- Also identified by DOI 10.1097/XCS.0000000000001130.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Before kidney transplantation (KT), most patients have an elevated parathyroid hormone (PTH). However, the impact of PTH on post-KT mortality and graft loss is unclear. We quantified the association between PTH levels measured at transplantation and adverse post-KT outcomes. We leveraged a prospective longitudinal cohort of 1,136 KT recipients from a single tertiary care center between December 2008 and February 2020. Pre-KT PTH levels were abstracted retrospectively. Adjusted multivariable Cox proportional hazards models were used to estimate the association between pre-KT PTH levels and mortality and death-censored graft loss (DCGL). Of 1,136 recipients, pre-KT PTH levels were 300 pg/mL or less in 62.3% and more than 600 pg/mL in 12.5%. Compared with those with a pre-KT PTH 300 pg/mL or less, patients with a pre-KT PTH more than 600 pg/mL were more likely to be Black (51.4% vs 34.6%) and have a longer dialysis vintage (4.8 vs 1.7 years, p < 0.001). Those with a pre-KT PTH more than 600 pg/mL had a higher 10-year cumulative incidence of DCGL than those with PTH 300 pg/mL or less (31.7% vs 15.4%, p < 0.001). After adjusting for confounders, pre-KT PTH more than 600 pg/mL was associated with a 1.76-fold increased risk of DCGL (95% CI 1.16 to 2.65). The magnitude of this association differed by race (p interaction = 0.011) and by treatment (p interaction = 0.018). Among non-Black patients, a PTH more than 600 pg/mL was associated with a 3.21-fold increased risk of DCGL compared with those with PTH 300 pg/mL or less (95% CI 1.77 to 5.81). Among untreated patients, those with PTH more than 600 pg/mL had a 2.54-fold increase in DCGL (95% CI 1.44 to 4.47). No association between pre-KT PTH and mortality risk was observed. PTH more than 600 pg/mL before KT increased the risk of DCGL by 76%, demonstrating the importance of treating PTH before KT to prevent graft loss in a contemporary era with the introduction and widespread availability of medical therapy.
Medical subject headings
- Kidney Transplantation
- Parathyroid Hormone
- Graft Rejection
- Postoperative Complications